Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors

Journal of Infection

Volumn 42, Issue 4, 2001, Pages 251-256

  Carbonara, S ^a   Fiorentino, G ^a   Serio, G ^a   Maggi, P ^a   Ingravallo, G ^a   Monno, L ^a   Bruno, F ^a   Coppola, S ^a   Pastore, G ^a   Angarano, G ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG RESPONSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MONOTHERAPY; PATIENT MONITORING; RELAPSE; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIREMIA; VIRUS LOAD;

EID: 0034928645     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2001.0833     Document Type: Article

References (36)

1. Hematologic manifestations of the human immunodeficiency virus (HIV)
2. Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia
3. Platelet kinetics in human immunodeficiency virus induced thrombocytopenia
4. Infection with the human immunodeficiency virus: Clinical manifestations and their relationship to immune deficiency
5. Epidemiology of thrombocytopenia in HIV infection
6. Treatment of human immunodeficiency virus-related thrombocytopenia with zidovudine
7. Pathophysiology of thrombocytopenia associated with HIV infection in homosexual men
8. Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA
9. Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenia purpura
10. Kinetic studies of the mechanisms of thrombocytopenia in patients with human immunodeficiency virus infection
11. Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets
12. Structural changes in the megakaryocytes of patients infected with the human immune deficiency virus (HIV-1)
13. Autoimmunity against blood cells in human immunodeficiency virus (HIV) infection
14. On the mechanism of thrombocytopenic purpura in sexually active homosexual men
15. Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric trial of the Cooperative Latin American Group on Hemostasis and Thrombosis
16. Low incidence of bleeding from HIV-related thrombocytopenia in drug addicts and haemophiliacs: Implications for therapeutic strategies
17. Prevalence, clinical and laboratory features of thrombocytopenia among HIV-infected individuals
18. Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV). A prospective study
19. HIV seropositive thrombocytopenia: The action of zidovudine
20. Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for HIV-related thrombocytopenia
21. Long-term treatment with zidovudine in patients with human immunodeficiency virus (HIV)-associated thrombocytopenia: Modes of response and correlation with markers of HIV replication
22. The long-term use of zidovudine in patients with severe immune-mediated thrombocytopenia secondary to infection with HIV
23. Response of HIV-associated thrombocytopenia to triple agent antiretroviral therapy
24. Lack of response of thrombocytopenia associated with human immunodeficiency virus to triple antiretroviral therapy
25. Effects of indinavir treatment on platelet and neutrophil counts in patients with advanced HIV disease
26. Elevation of platelet counts associated with indinavir treatment in human immunodeficiency virus-infected patients
27. Indinavir and thrombocytopenia
28. Effect of highly active antiretroviral therapy on thrombocytopenia in patients with HIV infection
29. Initial observations on the efficacy of highly active antiretroviral therapy in the treatment of HIV-associated autoimmune thrombocytopenia
30. Efficacy of protease inhibitor-based antiretroviral therapy in severe HIV-associated thrombocytopenia unresponsive to AZT
31. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
32. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
33. Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: A 5-year prospective study
34. Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual men
35. Correlation between platelet number and viral load in HIV-1 infection
36. + cell counts in HIV-1 infection